Evidence map›Paper›PMID 20482880›Full record

ArticleRetrovirology2010

Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2.

Chawaree Chaipan, Imke Steffen, Theodros Solomon Tsegaye, Stephanie Bertram, Ilona Glowacka, Yukinari Kato, Jan Schmökel, Jan Münch, Graham Simmons, Rita Gerardy-Schahn and 1 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Emerging Roles for Platelets in Inflammation and Disease.Journal of infectious disease and therapy · 2014
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Relationship of Podoplanin and Glutathione S-transferases T1 Expression with Laryngeal Cancer.International journal of molecular and cellular medicine · 2012
    Article
  12. Review
  13. Review
  14. Syk-coupled C-type lectins in immunity.Trends in immunology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Chawaree ChaipanNikolaus-Fiebiger-Center for Molecular Medicine, University Hospital Erlangen, Erlangen, Germany.
Imke Steffen
Theodros Solomon Tsegaye
Stephanie Bertram
Ilona Glowacka
Yukinari Kato
Jan Schmökel
Jan Münch
Graham Simmons
Rita Gerardy-Schahn
Stefan Pöhlmann
Medizinische Hochschule Hannover · DEUniversity Hospital Ulm · DEJapan Society for the Promotion of Science · JPUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlatelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream. The C-type lectin DC-SIGN and the novel HIV attachment factor CLEC-2 are expressed by platelets and facilitate HIV transmission from platelets to T-cells. Here, we studied the molecular mechanisms behind CLEC-2-mediated HIV-1 transmission.

resultsBinding studies with soluble proteins indicated that CLEC-2, in contrast to DC-SIGN, does not recognize the viral envelope protein, but a cellular factor expressed on kidney-derived 293T cells. Subsequent analyses revealed that the cellular mucin-like membranous glycoprotein podoplanin, a CLEC-2 ligand, was expressed on 293T cells and incorporated into virions released from these cells. Knock-down of podoplanin in 293T cells by shRNA showed that virion incorporation of podoplanin was required for efficient CLEC-2-dependent HIV-1 interactions with cell lines and platelets. Flow cytometry revealed no evidence for podoplanin expression on viable T-cells and peripheral blood mononuclear cells (PBMC). Podoplanin was also not detected on HIV-1 infected T-cells. However, apoptotic bystander cells in HIV-1 infected cultures reacted with anti-podoplanin antibodies, and similar results were obtained upon induction of apoptosis in a cell line and in PBMCs suggesting an unexpected link between apoptosis and podoplanin expression. Despite the absence of detectable podoplanin expression, HIV-1 produced in PBMC was transmitted to T-cells in a CLEC-2-dependent manner, indicating that T-cells might express an as yet unidentified CLEC-2 ligand.

conclusionsVirion incorporation of podoplanin mediates CLEC-2 interactions of HIV-1 derived from 293T cells, while incorporation of a different cellular factor seems to be responsible for CLEC-2-dependent capture of PBMC-derived viruses. Furthermore, evidence was obtained that podoplanin expression is connected to apoptosis, a finding that deserves further investigation.

Indexed as

Virus AttachmentCells, CulturedEpithelial CellsHIV-1HumansLectins, C-TypeLeukocytes, MononuclearMembrane GlycoproteinsPodoplaninVirionCLEC2B protein, humanLectins, C-TypeMembrane GlycoproteinsPDPN protein, humanPodoplanin

Identifiers

PMID20482880
PMCPMC2885308
OpenAlexW2122744431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.